T

Tempest Therapeutics
D

TPST

2.43000
USD
0.06
(2.53%)
مفتوح الان
حجم التداول
1,633
الربح لكل سهم
-3
العائد الربحي
-
P/E
-0
حجم السوق
32,759,000
المقالات

العنوان: Tempest Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.